Rapid Growth of E-Cigarettes in UK

Market by 2FIRSTS.ai
Dec.18.2023
Rapid Growth of E-Cigarettes in UK
E-cigarette becomes UK's fastest-growing grocery, prompting government measures against youth usage; global sales projected to reach $1.15 billion by 2023.

According to data released by The Grocer and market research company Nielsen in 2023, the fastest-growing grocery item in the UK is e-cigarettes, surpassing cigars, tobacco, and cigarettes.

 

Earlier, British Prime Minister Rishi Sunak also called for measures to be taken by the government regarding the use of e-cigarettes by teenagers. According to data from the U.S. Food and Drug Administration (FDA), over 3.6 million middle and high school students across the United States used e-cigarettes in 2018.

 

According to data shared by NIQ and The Grocer, the value sales of e-cigarette products in the UK have seen a significant increase. Market experts predict that e-cigarette sales are expected to reach $1.15 billion by 2023. Among them, the Lost Mary brand is the most popular e-cigarette product.

 

Marye, the e-cigarette brand, has experienced a remarkable surge in sales, surpassing £310 million (approximately $400 million) in 2022. This achievement positions it as one of the fastest-growing grocery items in the United Kingdom. In addition to impressive sales figures, NIQ, the company behind Marye, has announced a significant increase in e-cigarette sales. This indicates a growing trend among consumers who are increasingly opting to purchase these electronic alternatives to traditional cigarettes.

 

However, as more research uncovers the real threats posed by e-cigarette products, many countries are striving to ban their usage. Euro News reports that the UK government is planning to follow the example set by the Scottish government in restricting the use of e-cigarettes among young people. European Union member states are also announcing significant crackdowns on e-cigarette products, such as Ireland. Meanwhile, some other countries have already prohibited the use of e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
Haypp Reports 15% Q4 Sales Growth as Nicotine Pouch Volumes Rise
Haypp Reports 15% Q4 Sales Growth as Nicotine Pouch Volumes Rise
Haypp Group announced that net sales for October–December 2025 rose 15% year-on-year to SEK 1,052.2 million, or 19% in constant currency terms. The company recorded 28% volume growth in the nicotine pouch category during the quarter. The number of orders increased to 1.34 million, and active consumers rose to 630,000, marking the highest level in the company’s history. CEO Gavin O’Dowd said the company’s accelerating topline performance in the US and UK positions it for a strong 2026.
Market
Feb.22
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Galicia will implement a new “Minor Health Protection and Addictive Behaviors Prevention” law this Saturday, becoming the first region in Spain to ban the sale and use of vapes for people under 18.
Mar.09 by 2FIRSTS.ai
China’s E-cigarette Exports Reach $1.694 Billion in Jan–Feb 2026; U.S., UK, Germany Lead, Japan Rises to Fourth
China’s E-cigarette Exports Reach $1.694 Billion in Jan–Feb 2026; U.S., UK, Germany Lead, Japan Rises to Fourth
China Customs Administration released e-cigarette export data for January and February 2025, showing varied monthly performances in 2026.In January, the export value was $940 million, a decrease of 6.2% compared to January 2025's $1.02 billion. In February, the export value was $754 million, a 51.2% increase compared to February 2025's $498 million.
Mar.20 by 2FIRSTS.ai
UK reminds vaping firms to apply for new excise duty registration from April 2026
UK reminds vaping firms to apply for new excise duty registration from April 2026
HMRC has issued a reminder urging vaping manufacturers, importers and warehouse operators to prepare for registration under the UK’s new Vaping Products Duty, with applications opening in April 2026 and the duty taking effect in October.
Feb.10
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11